Chemistry and Industry - Safety concerns over Crestor
Monday, January 12th, 2009 There have been questions over the safety of Crestor, the cholesterol drug on which AstraZeneca has pinned most of its hopes for future growth.
US patient group Public Citizen has asked the US Food and Drug Administration (FDA), to withdraw the drug, following the death of a patient who suffered from a muscle damaging condition called rhabdomyolysis, Baycol, Bayer’s successful cholesterol-fighting drug, was withdrawn from the market in 2001, when it wa…
